Production (Stage)
Journey Medical Corporation
DERM
$7.10
-$0.29-3.92%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -367.78% | 163.64% | 28.89% | 67.81% | -387.26% |
| Total Depreciation and Amortization | 19.08% | 8.96% | -0.24% | 0.36% | 11.47% |
| Total Amortization of Deferred Charges | 7.45% | 8.05% | 35.94% | 3.23% | 3,000.00% |
| Total Other Non-Cash Items | 30.64% | -2.02% | -34.84% | 28.90% | 152.14% |
| Change in Net Operating Assets | 0.00% | -66.93% | 80.67% | -245.78% | 119.84% |
| Cash from Operations | -227.28% | 292.31% | 77.65% | -3.13% | 69.62% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 10,200.00% | -101.00% | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | -- | -- | -- |
| Issuance of Common Stock | -32.38% | 1,538.85% | 1,129.03% | -98.11% | -64.34% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -66.13% | 3,711.90% | -105.84% | 207.33% | -91.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 135.48% | -48.59% | -900.69% | 95.71% | -225.72% |